Quote | Good Works II Acquisition Corp. (NASDAQ:GWII)
Last: | $10.11 |
---|---|
Change Percent: | 0.0% |
Open: | $10.11 |
Close: | $10.11 |
High: | $10.11 |
Low: | $10.11 |
Volume: | 5,303 |
Last Trade Date Time: | 03/07/2023 03:00:00 am |
News | Good Works II Acquisition Corp. (NASDAQ:GWII)
Special purpose acquisition company Good Works II Acquisition ( NASDAQ: GWII ) is set to merge with the late-stage biotechnology company Direct Biologics. The latter will become a publicly traded company upon the closing of the transaction. The transaction involve...
Good Works II Acquisition Corp. (Nasdaq: GWII) (“Good Works II”), a publicly traded special purpose acquisition company (“SPAC”), and Direct Biologics, LLC (“Direct Biologics”), a late-stage biotechnology company, today announced the signing of ...
Message Board Posts | Good Works II Acquisition Corp. (NASDAQ:GWII)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Good Works II Acquisition Corp. Company Name:
GWII Stock Symbol:
NASDAQ Market:
Good Works II Acquisition Corp. (Nasdaq: GWII) (“Good Works II”), a publicly traded special purpose acquisition company (“SPAC”), and Direct Biologics, LLC (“Direct Biologics”), a late-stage biotechnology company, today announced the signing of ...
Direct Biologics leverages a proprietary extracellular vesicle platform technology designed to harness the power of bone marrow-derived mesenchymal stem cells to develop cell-free therapeutics Product candidate, ExoFlo ™ , is in a Phase 3 clinical trial for treating...